# Azio Ai Holdings, Inc.: financial statements, quarterly

AZIO · Nasdaq · CIK 1563568 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/azio.md) · [Financials](/companies/azio/financials.md) · [Filings](/companies/azio/filings.md) · [Insiders](/companies/azio/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/azio/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.1](/filings/0001437749-24-035310.md) | [0.1 d](/filings/0001437749-25-012095.md) | [0.8](/filings/0001437749-25-017820.md) | [0.8](/filings/0001437749-25-027166.md) | [0.0](/filings/0001437749-25-035760.md) | [0.2 d](/filings/0001437749-26-012170.md) | [0.6](/filings/0001437749-26-017803.md) | [1.0](/filings/0001437749-26-028254.md) | [1.8](/filings/0001437749-25-035760.md) | [2.5 d](/filings/0001437749-26-012170.md) | [2.2](/filings/0001437749-26-017803.md) | [2.7](/filings/0001437749-26-028254.md) |
| Cost of revenue | $m | [0.1](/filings/0001437749-24-035310.md) | [0.1 d](/filings/0001437749-25-012095.md) | [0.5](/filings/0001437749-25-017820.md) | [0.6](/filings/0001437749-25-027166.md) | [0.1](/filings/0001437749-25-035760.md) | [0.1 d](/filings/0001437749-26-012170.md) | [0.5](/filings/0001437749-26-017803.md) | [2.5](/filings/0001437749-26-028254.md) | [1.7](/filings/0001437749-25-035760.md) | [14.4 d](/filings/0001437749-26-012170.md) | [2.4](/filings/0001437749-26-017803.md) | [2.6](/filings/0001437749-26-028254.md) |
| Gross profit | $m | [0.0](/filings/0001437749-24-035310.md) | [(0.0) d](/filings/0001437749-25-012095.md) | [0.3](/filings/0001437749-25-017820.md) | [0.2](/filings/0001437749-25-027166.md) | [(0.1)](/filings/0001437749-25-035760.md) | [0.1 d](/filings/0001437749-26-012170.md) | [0.1](/filings/0001437749-26-017803.md) | [(1.5)](/filings/0001437749-26-028254.md) | [0.1](/filings/0001437749-25-035760.md) | [(11.9) d](/filings/0001437749-26-012170.md) | [(0.2)](/filings/0001437749-26-017803.md) | [0.1](/filings/0001437749-26-028254.md) |
| Research and development | $m | [0.0](/filings/0001437749-24-035310.md) | [0.1 d](/filings/0001437749-25-012095.md) | [0.1](/filings/0001437749-25-017820.md) | [0.1](/filings/0001437749-25-027166.md) | [0.0](/filings/0001437749-25-035760.md) | [0.0 d](/filings/0001437749-26-012170.md) | [0.1](/filings/0001437749-26-017803.md) | [0.6](/filings/0001437749-26-028254.md) | [0.0](/filings/0001437749-25-035760.md) | [0.0 d](/filings/0001437749-26-012170.md) | [0.0](/filings/0001437749-26-017803.md) | [0.0](/filings/0001437749-26-028254.md) |
| Operating income | $m | [(6.0)](/filings/0001437749-24-035310.md) | [(3.2) d](/filings/0001437749-25-012095.md) | [(3.0)](/filings/0001437749-25-017820.md) | [(1.3)](/filings/0001437749-25-027166.md) | [(1.6)](/filings/0001437749-25-035760.md) | [(2.0) d](/filings/0001437749-26-012170.md) | [(13.7)](/filings/0001437749-26-017803.md) | [(4.8)](/filings/0001437749-26-028254.md) | [(6.1)](/filings/0001437749-25-035760.md) | [(14.1) d](/filings/0001437749-26-012170.md) | [(3.8)](/filings/0001437749-26-017803.md) | [(5.7)](/filings/0001437749-26-028254.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001437749-24-035310.md) | [0.0 d](/filings/0001437749-25-012095.md) | [0.0](/filings/0001437749-25-017820.md) | [0.0](/filings/0001437749-25-027166.md) | [0.0](/filings/0001437749-25-035760.md) | [0.0 d](/filings/0001437749-26-012170.md) | [0.0](/filings/0001437749-26-017803.md) | [0.0](/filings/0001437749-26-028254.md) | [0.0](/filings/0001437749-25-035760.md) | [0.0 d](/filings/0001437749-26-012170.md) | [0.0](/filings/0001437749-26-017803.md) | [0.0](/filings/0001437749-26-028254.md) |
| Net income | $m | [(6.0)](/filings/0001437749-24-035310.md) | [(3.2) d](/filings/0001437749-25-012095.md) | [(4.5)](/filings/0001437749-25-035760.md) | [(0.8)](/filings/0001437749-25-035760.md) | [(1.2)](/filings/0001437749-25-035760.md) | [2.3 d](/filings/0001437749-26-017803.md) | [(14.0)](/filings/0001437749-26-028254.md) | [(5.1)](/filings/0001437749-26-028254.md) | [(6.4)](/filings/0001437749-25-035760.md) | [22.2 d](/filings/0001437749-26-017803.md) | [(4.0)](/filings/0001437749-26-028254.md) | [(6.6)](/filings/0001437749-26-028254.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [(0.40)](/filings/0001437749-24-035310.md) | not reported | [(0.29)](/filings/0001437749-25-017820.md) | [(0.48)](/filings/0001437749-25-027166.md) | [(0.76)](/filings/0001437749-25-035760.md) | not reported | [(6.44)](/filings/0001437749-26-017803.md) | [(2.01)](/filings/0001437749-26-028254.md) | [(1.79)](/filings/0001437749-25-035760.md) | not reported | [(0.31)](/filings/0001437749-26-017803.md) | [(0.46)](/filings/0001437749-26-028254.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.9](/filings/0001437749-23-032000.md) | [0.5](/filings/0001437749-25-012095.md) | [1.0](/filings/0001437749-24-017090.md) | [0.4](/filings/0001437749-24-026785.md) | [0.7](/filings/0001437749-24-035310.md) | [1.9](/filings/0001437749-26-012170.md) | [0.2](/filings/0001437749-25-017820.md) | [0.9](/filings/0001437749-25-027166.md) | [0.1](/filings/0001437749-25-035760.md) | [0.4](/filings/0001437749-26-028254.md) | [2.0](/filings/0001437749-26-017803.md) | [0.1](/filings/0001437749-26-028254.md) |
| Current assets | $m | [13.6](/filings/0001437749-23-032000.md) | [12.1](/filings/0001437749-25-012095.md) | [12.6](/filings/0001437749-24-017090.md) | [12.0](/filings/0001437749-24-026785.md) | [12.2](/filings/0001437749-24-035310.md) | [17.6](/filings/0001437749-26-012170.md) | [20.1](/filings/0001437749-25-017820.md) | [16.3](/filings/0001437749-25-027166.md) | [15.5](/filings/0001437749-25-035760.md) | [3.5](/filings/0001437749-26-028254.md) | [6.8](/filings/0001437749-26-017803.md) | [4.1](/filings/0001437749-26-028254.md) |
| Total assets | $m | [25.4](/filings/0001437749-23-032000.md) | [22.7](/filings/0001437749-25-012095.md) | [23.2](/filings/0001437749-24-017090.md) | [22.5](/filings/0001437749-24-026785.md) | [22.8](/filings/0001437749-24-035310.md) | [32.7](/filings/0001437749-26-012170.md) | [24.8](/filings/0001437749-25-017820.md) | [22.7](/filings/0001437749-25-027166.md) | [18.2](/filings/0001437749-25-035760.md) | [4.7](/filings/0001437749-26-028254.md) | [11.2](/filings/0001437749-26-017803.md) | [15.6](/filings/0001437749-26-028254.md) |
| Current liabilities | $m | [1.6](/filings/0001437749-23-032000.md) | [1.8](/filings/0001437749-25-012095.md) | [4.5](/filings/0001437749-24-017090.md) | [4.3](/filings/0001437749-24-026785.md) | [3.6](/filings/0001437749-24-035310.md) | [11.7](/filings/0001437749-26-012170.md) | [15.7](/filings/0001437749-25-017820.md) | [16.4](/filings/0001437749-25-027166.md) | [16.0](/filings/0001437749-25-035760.md) | [13.3](/filings/0001437749-26-028254.md) | [18.3](/filings/0001437749-26-017803.md) | [26.9](/filings/0001437749-26-028254.md) |
| Total liabilities | $m | [1.6](/filings/0001437749-23-032000.md) | [2.0](/filings/0001437749-25-012095.md) | [4.7](/filings/0001437749-24-017090.md) | [4.4](/filings/0001437749-24-026785.md) | [3.9](/filings/0001437749-24-035310.md) | [11.7](/filings/0001437749-26-012170.md) | [15.7](/filings/0001437749-25-017820.md) | [16.8](/filings/0001437749-25-027166.md) | [16.3](/filings/0001437749-25-035760.md) | [13.6](/filings/0001437749-26-028254.md) | [19.4](/filings/0001437749-26-017803.md) | [27.9](/filings/0001437749-26-028254.md) |
| Long-term debt | $m | not reported | [0.3](/filings/0001437749-24-009818.md) | [1.1](/filings/0001437749-24-017090.md) | [1.3](/filings/0001437749-24-026785.md) | [0.9](/filings/0001437749-24-035310.md) | [3.4](/filings/0001437749-25-012095.md) | [4.6](/filings/0001437749-25-017820.md) | [4.9](/filings/0001437749-25-027166.md) | [2.9](/filings/0001437749-25-035760.md) | [0.5](/filings/0001437749-26-012170.md) | [4.5](/filings/0001437749-26-017803.md) | [10.7](/filings/0001437749-26-028254.md) |
| Shareholders' equity | $m | [23.8](/filings/0001437749-24-035310.md) | [20.6](/filings/0001437749-26-012170.md) | [18.5](/filings/0001437749-25-035760.md) | [18.1](/filings/0001437749-25-035760.md) | [19.0](/filings/0001437749-25-035760.md) | [20.9](/filings/0001437749-26-028254.md) | [9.2](/filings/0001437749-26-028254.md) | [5.9](/filings/0001437749-26-028254.md) | [1.9](/filings/0001437749-25-035760.md) | [(8.9)](/filings/0001437749-26-028254.md) | [(8.2)](/filings/0001437749-26-028254.md) | [(12.4)](/filings/0001437749-26-028254.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.0) d](/filings/0001437749-24-035310.md) | [(0.7) d](/filings/0001437749-25-012095.md) | [(0.7)](/filings/0001437749-25-017820.md) | [(1.0) d](/filings/0001437749-25-027166.md) | [(1.1) d](/filings/0001437749-25-035760.md) | [(0.7) d](/filings/0001437749-26-012170.md) | [(4.2)](/filings/0001437749-26-017803.md) | [(1.2) d](/filings/0001437749-26-028254.md) | [(0.9) d](/filings/0001437749-25-035760.md) | [(110) d](/filings/0001437749-26-017803.md) | [(3.3)](/filings/0001437749-26-017803.md) | [(5.4) d](/filings/0001437749-26-028254.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001437749-24-035310.md) | [(0.0) d](/filings/0001437749-25-012095.md) | [0.0](/filings/0001437749-25-017820.md) | [0.1 d](/filings/0001437749-25-027166.md) | [0.1 d](/filings/0001437749-25-035760.md) | [0.2 d](/filings/0001437749-26-012170.md) | [0.2](/filings/0001437749-26-017803.md) | [0.0 d](/filings/0001437749-26-028254.md) | [0.0 d](/filings/0001437749-25-035760.md) | [0.0 d](/filings/0001437749-26-012170.md) | [1.5](/filings/0001437749-26-017803.md) | [3.2 d](/filings/0001437749-26-028254.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [13.9](/filings/0001193125-22-221237.md) | [14.7](/filings/0001193125-22-284630.md) | [15.0](/filings/0001193125-22-221237.md) | [15.0](/filings/0001193125-22-284630.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,467,848 at 2026-08-12, from the cover of the [10-Q filed 2026-08-18](/filings/0001437749-26-028254.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.